易生活控股(00223.HK)擬溢價約5.77%發行1.45億股 淨籌770萬港元
格隆匯7月19日丨易生活控股(00223.HK)公吿,於2021年7月19日,公司與認購人(公司兩間非全資附屬公司主要股東朱其安)訂立認購協議。根據認購協議,公司有條件同意配發及發行,而認購人亦有條件同意按認購價每股認購股份0.055港元認購1.45億股認購股份,所涉代價797.5萬港元。認購價每股認購股份0.055港元較7月19日收市價每股0.052港元溢價約5.77%。
認購股份相當於經發行認購股份擴大後公司已發行股本約4.36%(假設公司股本於認購協議日期起至完成日期止並無其他變動)。所得款項淨額將約為770萬港元,相當於淨認購價每股認購股份約0.0531港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.